Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of AGRIPPAL S1 influenza vaccine (2006–2007 formulation) in non-elderly adults and elderly subjects
2006-000609-43Phase 2Completed
- Sponsor
- Chiron Corporation
- Start
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of influenza vaccine, inactivated, surface antigen in influenza (2 arms), sponsored by Chiron Corporation. Primary endpoints: Immunogenicity by Single Radial Hemolysis and Safety of single intramuscular injection of AGRIPPAL S1. Started Jul 2007; status: completed.
02
Drugs
influenza vaccine, inactivated, surface antigen
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-000609-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000609-43.